Public Profile

Biocon

Biocon Limited, a leading biopharmaceutical company headquartered in Bengaluru, India, has established itself as a key player in the global biotechnology industry since its founding in 1978. With a strong focus on biopharmaceuticals, biosimilars, and novel biologics, Biocon operates across major regions including Asia, Europe, and North America. The company is renowned for its innovative products, particularly in the fields of diabetes, oncology, and autoimmune diseases. Biocon's commitment to affordability and accessibility sets it apart, making significant strides in providing high-quality healthcare solutions. Notable achievements include the launch of India's first biosimilar monoclonal antibody and recognition as a pioneer in the biosimilars market. With a robust pipeline and a reputation for excellence, Biocon continues to shape the future of biotechnology on a global scale.

DitchCarbon Score

How does Biocon's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

48

Industry Average

Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

26

Industry Benchmark

Biocon's score of 48 is higher than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.

87%

Let us know if this data was useful to you

Biocon's reported carbon emissions

In 2024, Biocon reported total carbon emissions of approximately 125,922,000 kg CO2e, comprising 23,273,000 kg CO2e from Scope 1, 25,307,000 kg CO2e from Scope 2, and 77,342,000 kg CO2e from Scope 3 emissions. This represents a slight decrease from 2023, where total emissions were about 131,095,000 kg CO2e, with Scope 1 emissions at 31,456,000 kg CO2e, Scope 2 at 31,809,000 kg CO2e, and Scope 3 at 67,830,000 kg CO2e. Biocon has set ambitious climate commitments, aiming for a 25% reduction in Scope 1 and Scope 2 emissions by the end of FY29, using FY20 as the baseline. Additionally, they have an internal target of a 20% reduction in these emissions by 2032, having already achieved a 14% reduction from the FY22 baseline. Syngene, a subsidiary, has also committed to a 50% reduction in GHG emissions by FY33. These initiatives reflect Biocon's commitment to addressing climate change and reducing its carbon footprint in line with industry standards.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2021202220232024
Scope 1
55,997,000
000,000,000
00,000,000
00,000,000
Scope 2
127,530,000
00,000,000
00,000,000
00,000,000
Scope 3
-
00,000,000
00,000,000
00,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Biocon's primary industry is Chemicals nec, which is medium in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Biocon is in IN, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Biocon is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Ipca Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Jubilant Life Sciences

IN
Pharmaceutical Preparation Manufacturing
Updated about 2 hours ago

Shire plc

IE
Health and social work services (85)
Updated 3 months ago
DitchCarbon Score

Alkem Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 22 days ago

Cipla

IN
Pharmaceutical Preparation Manufacturing
Updated 7 days ago

Divis Laboratories

IN
Pharmaceutical Preparation Manufacturing
Updated 10 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers